Tag: VigilareBP

By Vigilare Biopharma July 11, 2026Pharmacovigilance

Pharmacovigilance Inspection Readiness Documents, SOPs, and Audit Preparat

Pharmacovigilance (PV) inspection should begin even before a health authority plans a visit. Inspection readiness relies heavily on an existing quality system, accurate and periodic documentation, and clear ownership of safety responsibilities throughout the organization.

Read More
By Vigilare Biopharma June 25, 2026Pharmacovigilance

FDA, EMA, and DCGI Inspections: Common Findings and CAPA Best Practices

Regulatory inspections can feel unpredictable, but most findings follow similar tendencies across FDA, EMA, and DCGI reviews. A strong FDA inspection-readiness mindset is not about preparing for one visit; it is about building a system

Read More